California Becomes 32nd State to Pass "Right to Try" Law for Terminally Ill
Terminally ill patients in Golden State will now be able to legally use medicines not yet out of the FDA's approval process that might help them.
Terminally ill patients in Golden State will now be able to legally use medicines not yet out of the FDA's approval process that might help them.
A new study adds to the evidence that letting patients use cannabis saves lives by reducing consumption of pharmaceuticals.
A new study adds to the evidence that patients are substituting marijuana for opioids.
"Our goal is to make sure this is available," a spokesman says.
Drug company Mylan is able to charge monopoly prices due to government regulation, not free-market forces.
Last year a woman went into respiratory failure when a medic shot her with ketamine to help cops subdue her.
Capitalism isn't to blame. It's the exact opposite.
Short dramatic film from Institute for Justice lays out the case for paying the people who give marrow, organs, and more.
With NIDA as the only legal source of cannabis for research, meeting FDA requirements was impossible.
The Affordable Care Act (ACA) has always been an alliance of big business and big government.
Has the entire U.S. Olympic team fallen for the superstition of cupping?
After a dog supposedly alerted to her at a border crossing, she endured six hours of fruitless body cavity searches.
Before the medical professionals figured out what was causing an outbreak, country and blues musicians were on the case.
Nearly 2 years more of disability-free life expectancy
Whether he's right about the GOP presidential nominee, Chopra has a lot of explaining to do about why his brand of medicine gets taxpayer support.
Vascular Solutions CEO Howard Root faced years of jail time in a legal battle over off-label use that has profound implications for medical innovation in America.
Reason's choice of SXSW's innovator awards
To shrink the supply of opioids, the agency encourages doctors to be suspicious and stingy.
Why should not men be eligible for uterine transplants?
England's National Health Service years behind in understanding treatment needs.
What happens when cancer doctors, psychologists, and drug developers can't rely on each other's research?
States are moving to make contraception more accessible, with the charge being led by Republican men.
New collaboration announced to use precision medicine techniques to cure cancer
I'm a bioethicist, and I am here to help slow down scientific and medical progress
"Right to try" laws offer hope for people trying to save their own lives.
Millions of people could shake Type 2 diabetes if they just lost some weight.
The evidence concerning marijuana's effect on fetuses is mixed and incomplete.
The evidence does not support the claim that cannabis poses an unacceptable risk to fetuses.
County social workers said separating the newborn from her parents would be harmful.
A California doctor's conviction is bound to have a chilling effect on pain treatment.
And still the ultimate death rate remains frustratingly stuck at 100 percent.
Allows mentally competent adults with terminal illnesses to legally get life-ending drugs.
The vast reach of government as a payer for health care means that drug companies are to a large degree government contractors, and patients are suffering.
California could become the fifth state to misidentify suicide as a medical treatment.
Let us decide for ourselves if genetic ignorance is bliss.
The NIH has spent $5.5 billion on bringing quackery-from faith healing to homeopathy-right into the heart of the American medical establishment.
Modafinil is "one of the most promising neuroenhancers to date"-and still a controlled substance in the U.S.
Art was the first neurotechnology: A feel-good video to start your weekend
Drug advances can stop the spread of the virus, if we can get them into the right people's hands.
"Schedule II is absolutely easier to research," says Kevin Sabet.
Obstacles to research are crumbling, with support from drug warriors.
Even prohibitionists agree that the process for approving studies should be streamlined.
The authors say the evidence supporting most other applications is weak.